|
1
|
El-Assal ON, Yamanoi A, Ono T, Kohno H and
Nagasue N: The clinicopathological significance of heparanase and
basic fibroblast growth factor expressions in hepatocellular
carcinoma. Clin Cancer Res. 7:1299–1305. 2001.PubMed/NCBI
|
|
2
|
Chen XP, Liu YB, Rui J, Peng SY, Peng CH,
Zhou ZY, Shi LH, Shen HW and Xu B: Heparanase mRNA expression and
point mutation in hepatocellular carcinoma. World J Gastroenterol.
10:2795–2799. 2004.PubMed/NCBI
|
|
3
|
Komatsu N, Waki M, Sue M, Tokuda C,
Kasaoka T, Nakajima M, Higashi N and Irimura T: Heparanase
expression in B16 melanoma cells and peripheral blood neutrophils
before and after extravasation detected by novel anti-mouse
heparanase monoclonal antibodies. J Immunol Methods. 331:82–93.
2008. View Article : Google Scholar
|
|
4
|
Ilan N, Elkin M and Vlodavsky I:
Regulation, function and clinical significance of heparanase in
cancer metastasis and angiogenesis. Int J Biochem Cell Biol.
38:2018–2039. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yingying X, Yong Z, Zhenning W, Xue Z, Li
J, Yang L and Huimian X: Role of heparanase-1 in gastric carcinoma
invasion. Asian Pac J Cancer Prev. 10:151–154. 2009.PubMed/NCBI
|
|
6
|
Kussie PH, Hulmes JD, Ludwig DL, Patel S,
Navarro EC, Seddon AP, Giorgio NA and Bohlen P: Cloning and
functional expression of a human heparanase gene. Biochem Biophys
Res Commun. 261:183–187. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vlodavsky I, Friedmann Y, Elkin M, Aingorn
H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal
I, et al: Mammalian heparanase: gene cloning, expression and
function in tumor progression and metastasis. Nat Med. 5:793–802.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Toyoshima M and Nakajima M: Human
heparanase. Purification, characterization, cloning and expression.
J Biol Chem. 274:24153–24160. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hulett MD, Freeman C, Hamdorf BJ, Baker
RT, Harris MJ and Parish CR: Cloning of mammalian heparanase, an
important enzyme in tumor invasion and metastasis. Nat Med.
5:803–809. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang P, Kumar A, Parrillo JE, Dempsey LA,
Platt JL, Prinz RA and Xu X: Cloning and characterization of the
human heparanase-1 (HPR1) gene promoter: role of GA-binding peotein
and Sp1 in regulating HPR1 BASAL promoter activity. J Biol Chem.
277:8989–8998. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Mestre AM, Rao S, Hornby JR, Soe-Htwe
T, Khachigian LM and Hulett MD: Early growth response gene 1 (EGR1)
regulates heparanase gene transcription in tumor cells. J Biol
Chem. 280:35136–35147. 2005.
|
|
12
|
Boyd DD and Nakajima M: Involvement of
heparanase in tumor metastases: A new target in cancer therapy? J
Natl Cancer Inst. 96:1194–1195. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang JM, Wang HJ, Du L, Han XM, Ye ZY,
Fang Y, Tao HQ, Zhao ZS and Zhou YL: Screening and identification
of novel B cell epitopes in human heparanase and their
anti-invasion property for hepatocellular carcinoma. Cancer Immunol
Immunother. 58:1387–1396. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song MS, Jeong JS, Ban G, Lee JH, Won YS,
Cho KS, Kim IH and Lee SW: Validation of tissue-specific
promoter-driven tumor-targeting trans-splicing ribozyme system as a
multifunctional cancer gene therapy device in vivo. Cancer Gene
Ther. 16:113–125. 2009. View Article : Google Scholar
|
|
15
|
Fukazawa T, Maeda Y, Durbin ML, Nakai T,
Matsuoka J, Tanaka H, Naomoto Y and Tanaka N: Pulmonary
adenocarcinoma-targeted gene therapy by a cancer- and
tissue-specific promoter system. Mol Cancer Ther. 6:244–252. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huyn ST, Burton JB, Sato M, Carey M,
Gambhir SS and Wu L: A potent, imaging adenoviral vector driven by
the cancer-selective mucin-1 promoter that targets breast cancer
metastasis. Clin Cancer Res. 15:3126–3134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Willhauck MJ, Sharif Samani BR, Klutz K,
Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R,
Göke B, et al: Alpha-fetoprotein promoter-targeted sodium iodide
symporter gene therapy of hepatocellular carcinoma. Gene Ther.
15:214–223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qiao J, Doubrovin M, Sauter BV, Huang Y,
Guo ZS, Balatoni J, Akhurst T, Blasberg RG, Tjuvajev JG, Chen SH
and Woo SL: Tumor-specific transcriptional targeting of suicide
gene therapy. Gene Ther. 9:168–175. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kraaij R, van der Weel L, de Ridder CM,
van der Korput HA, Zweistra JL, van Rijswijk AL, Bangma CH and
Trapman J: A small chimeric promoter for high prostate-specific
transgene expression from adenoviral vectors. Prostate. 67:829–839.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murofushi Y, Nagano S, Kamizono J,
Takahashi T, Fujiwara H, Komiya S, Matsuishi T and Kosai K: Cell
cycle-specific changes in hTERT promoter activity in normal and
cancerous cells in adenoviral gene therapy: A promising implication
of telomerase-dependent targeted cancer gene therapy. Int J Oncol.
29:681–688. 2006.
|
|
21
|
Wang X, Ji C, Ma D, Zhao J, Hou M, Yu H
and Zang S: Antitumor effects of cytosine deaminase and thymidine
kinase fusion suicide gene under the control of mdr1 promoter in
mdr1 positive leukemia cells. Leuk Lymphoma. 48:1600–1609. 2007.
View Article : Google Scholar : PubMed/NCBI
|
